Autoreactive CD8 T cells in organ-specific autoimmunity: Emerging targets for therapeutic intervention

被引:160
作者
Liblau, RS
Wong, FS [1 ]
Mars, LT
Santamaria, P
机构
[1] Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England
[2] Toulouse Univ Hosp, INSERM U563, Toulouse, France
[3] Toulouse Univ Hosp, Immunol Lab, Toulouse, France
[4] Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada
关键词
D O I
10.1016/S1074-7613(02)00338-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of CD8 T cells in the pathogenesis of organ-specific autoimmune diseases has not previously been well recognized. Recent evidence, however, indicates that autoreactive CD8 T cells can contribute substantially to tissue damage in both murine and human autoimmune disorders. As such, these T cells now become an attractive target for therapeutic intervention.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 32 条
[1]   Tumor-specific killer cells in paraneoplastic cerebellar degeneration [J].
Albert, ML ;
Darnell, JC ;
Bender, A ;
Francisco, LM ;
Bhardwaj, N ;
Darnell, RB .
NATURE MEDICINE, 1998, 4 (11) :1321-1324
[2]   Progression of autoimmune diabetes driven by avidity maturation of a T-cell population [J].
Amrani, A ;
Verdaguer, J ;
Serra, P ;
Tafuro, S ;
Tan, RS ;
Santamaria, P .
NATURE, 2000, 406 (6797) :739-742
[3]   CD154-dependent priming of diabetogenic CD4+ T cells dissociated from activation of antigen-presenting cells [J].
Amrani, A ;
Serra, P ;
Yamanouchi, J ;
Han, BY ;
Thiessen, S ;
Verdaguer, J ;
Santamaria, P .
IMMUNITY, 2002, 16 (05) :719-732
[4]   Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes [J].
Anderson, B ;
Park, BJ ;
Verdaguer, J ;
Amrani, A ;
Santamaria, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :9311-9316
[5]   Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction [J].
Babbe, H ;
Roers, A ;
Waisman, A ;
Lassmann, H ;
Goebels, N ;
Hohlfeld, R ;
Friese, M ;
Schröder, R ;
Deckert, M ;
Schmidt, S ;
Ravid, R ;
Rajewsky, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :393-404
[6]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[7]   Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor α chain gene rearrangement [J].
DiLorenzo, TP ;
Graser, RT ;
Ono, T ;
Christianson, GJ ;
Chapman, HD ;
Roopenian, DC ;
Nathenson, SG ;
Serreze, DV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12538-12543
[8]  
Garza KM, 2002, EUR J IMMUNOL, V32, P885, DOI 10.1002/1521-4141(200203)32:3<885::AID-IMMU885>3.0.CO
[9]  
2-E
[10]   Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions [J].
Graser, RT ;
DiLorenzo, TP ;
Wang, FM ;
Christianson, GJ ;
Chapman, HD ;
Roopenian, DC ;
Nathenson, SG ;
Serreze, DV .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3913-3918